Global Weight-Loss Deal Activity in 2025 H1: Partnerships and New Drug Investments In H1 2025, the weight-loss sector and metabolic diseases saw a flurry of dealmaking
Real-world use of once-weekly semaglutide in type 2 diabetes: results from semaglUtide real-world evidence (SURE) Germany
Pitchika, in Agric
About GLP-1 and GIP Medications Originally developed for type 2 diabetes management, GLP-1 receptor agonists like Tirzepatide, Ozempic, Wegovy, and Semaglutide are now widely recognized for their impressive weight loss benefits
Biomed Reports 7:407415
A Biotype Evaluation Can Give You Clear Answers If you are recognizing these patterns emotional storms, sensory overload, rigid routines, developmental delays, or inconsistent gains with therapy your child may fit one or more of the core biotypes common in autism: undermethylation , copper overload , or oxidative stress